These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38765726)

  • 41. Topical immunotherapy in alopecia areata.
    Singh G; Lavanya M
    Int J Trichology; 2010 Jan; 2(1):36-9. PubMed ID: 21188022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India.
    Gowda SK; Aggarwal A; Thakur V; Behera B; Garg S; Sethy M; Ayyanar P
    J Cutan Med Surg; 2024 Jul; ():12034754241266128. PubMed ID: 39056399
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
    Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
    Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A retrospective study on the clinical characteristics and prognosis of alopecia totalis and universalis: An update on prognosis.
    Choi SM; Kang MJ; Kwon SH; Sim WY; Lew BL
    J Dermatol; 2023 Oct; 50(10):1335-1338. PubMed ID: 37208851
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors Affecting the Response and Patient Satisfaction of Topical Immunotherapy in Alopecia Areata: A Nationwide Study.
    Lee Y; Kim K; Lew BL; Huh CH; Kang H; Jang YH; Kim DY; Shin HT; Kim MB; Park J; Kim MS; Choi GS
    Ann Dermatol; 2024 Aug; 36(4):225-230. PubMed ID: 39082658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. PUVA treatment of alopecia areata totalis and universalis: a retrospective study.
    Whitmont KJ; Cooper AJ
    Australas J Dermatol; 2003 May; 44(2):106-9. PubMed ID: 12752182
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study.
    Uzuncakmak TK; Engin B; Serdaroglu S; Tuzun Y
    Skin Appendage Disord; 2021 Jan; 7(1):8-12. PubMed ID: 33614711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib.
    Cai L; Wei Y; Zhao M; Zhuo J; Tao X; Lin M
    Front Med (Lausanne); 2023; 10():1253795. PubMed ID: 37877023
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Imiquimod-enhanced immunotherapy with diphencyprone for patients with alopecia areata.
    Díaz-Guimaraens B; Saceda-Corralo D; Hermosa-Gelbard Á; Moreno-Arrones ÓM; Dominguez-Santas M; Suarez-Valle A; Vañó-Galván S
    Dermatol Ther; 2022 Jul; 35(7):e15516. PubMed ID: 35421278
    [TBL] [Abstract][Full Text] [Related]  

  • 50. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials.
    King B; Shapiro J; Ohyama M; Egeberg A; Piraccini BM; Craiglow B; Sinclair R; Chen YF; Wu WS; Ding Y; Somani N; Dutronc Y
    Br J Dermatol; 2023 Nov; 189(6):666-673. PubMed ID: 37708254
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective management Alopecia totalis by Ayurveda - A case report.
    Patil SB; Patil GS; Patil V
    J Ayurveda Integr Med; 2023; 14(6):100805. PubMed ID: 38043433
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
    Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
    J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population.
    Mostaghimi A; Gao W; Ray M; Bartolome L; Wang T; Carley C; Done N; Swallow E
    JAMA Dermatol; 2023 Apr; 159(4):411-418. PubMed ID: 36857069
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Alopecia areata].
    Friedli A; Harms M
    Ther Umsch; 2002 May; 59(5):233-7. PubMed ID: 12090120
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population.
    AlMarzoug A; AlOrainy M; AlTawil L; AlHayaza G; AlAnazi R; AlIssa A; AlSheikh A; AlKhalifah A; AlHarithy R
    Int J Dermatol; 2022 Jul; 61(7):886-894. PubMed ID: 34716573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
    Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
    J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial.
    Tosti A; Iorizzo M; Botta GL; Milani M
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1243-7. PubMed ID: 17062039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of alopecia areata with squaric acid dibutylester.
    Micali G; Cicero RL; Nasca MR; Sapuppo A
    Int J Dermatol; 1996 Jan; 35(1):52-6. PubMed ID: 8838932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pulsed administration of corticosteroids in the treatment of alopecia areata.
    Sharma VK
    Int J Dermatol; 1996 Feb; 35(2):133-6. PubMed ID: 8850047
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata.
    Cotellessa C; Peris K; Caracciolo E; Mordenti C; Chimenti S
    J Am Acad Dermatol; 2001 Jan; 44(1):73-6. PubMed ID: 11148480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.